📰 Multiple Sclerosis News
Page 91 - Multiple Sclerosis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple Sclerosis. Real-time updates on events, politics, business and more.
October 27, 2023
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase III
October 27, 2023
Bristol Myers Squibb on Thursday pushed back by a year the time frame for its new-product portfolio to hit $10 billion in revenue as the sales ramp-up of medicines such as psoriasis treatment Sotyktu and multiple sclerosis drug Zeposia takes longer than initially projected.
October 27, 2023
Results highlighted a growing number of incident cases of asthma, inflammatory bowel disease, multiple sclerosis, psoriasis, atopic dermatitis, and rheumatoid arthritis from 1990 to 2019.
October 26, 2023
Researchers are exploring HSCT as a rescue therapy in early-stage MS. But theres no consensus on best practices.
October 26, 2023
A WOMAN is walking 400 miles to help raise money for people affected by a debilitating condition that her grandmother has suffered with for 40 years.
October 26, 2023
Anti-CD20 antibody therapy can be effectively and safely administered subcutaneously to patients with MS, even when switching from a prior treatment, two clinical trials suggest.
October 26, 2023
A led steer charity auction at Brisbane's historic Breakfast Creek Hotel last week, raised $35,000 for vital multiple...
October 26, 2023
Shares of Clene Inc. (NASDAQ:CLNN – Get Free Report) have earned a consensus rating of “Buy” from the six analysts that are covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued a report on the stock in […]
October 26, 2023
Letters from around the North County